$16.5 million U.S. Initial Public Offering. Nasdaq Capital market listing 

Highlights:

• Emerging digital healthcare company with a proprietary ECG telemedicine technology to bring new medical-grade heart attack detection technology for the treatment and prevention of cardiovascular disease
• Firm commitment underwritten initial public offering of 2,750,000 units, each consisting of (i) one share of common stock and (ii) one warrant to purchase a share of common stock

“Working with Exchange Listing as IPO counsel put us in a winning position. Their exemplary team put us in contact with a best-in-class investment banker and legal team. We are thrilled to now be listed on the Nasdaq Capital Markets.”  said Branislav Vajdic, CEO

Key Deliverables:

• Introduction, negotiation, and management of underwriter for firm commitment offering
• Successful management and integration of complex compliance with Nasdaq, SEC regulatory, corporate governance, and legal listing requirements
• Ongoing engagement post-listing for ongoing capital market support